Research Society

 
News Articles for Research Society top ^
- Musicians OneRepublic, Paulina Rubio, Nelly, Justin Moore, 3lau, Capital Cities, Botnek and More Are Coming Together to Spread the Message of This Promotion - LOS ANGELES , Nov.
Sign-up for The American Cancer Society Launches 'Rock Out And Save Lives' Get And Give Ticketmaster Ticket Cash Promotion With Live Nation Entertainment investment picks
2014/12/19
79 students join international academic honors society at Dec.
Sign-up for Hoosier Academies Celebrates Entry into National Honor Society with First-Ever Induction Ceremony investment picks
The Medicines Company (NASDAQ:MDCO) today announced that data from two health economics analyses will be presented at the 17 th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) being held in Amsterdam, November 8-12.
Sign-up for Health Economic Data on The Medicines Company’s Infectious Disease and Cardiology Portfolios to be Presented at the 17th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) investment picks
YAVNE, Israel, Oct.
Sign-up for MediWound's NexoBrid to be Featured at International Society for Burn Injuries 2014 investment picks
California Middle Schooler Wins Grand Prize for her Project on the Science of Sewing WASHINGTON , Oct.
Sign-up for Broadcom Foundation and Society for Science & the Public Announce 2014 Broadcom MASTERS National Science Fair Winners investment picks
La Jolla Pharmaceutical Company (Nasdaq: LJPC) (“the Company” or “La Jolla”), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that an abstract of the results for the Company’s Phase 2 clinical trial of GCS-100 in chronic kidney disease (CKD) has been selected by the American Society of Nephrology’s (ASN) Program Committee for poster presentation at the Kidney Week Annual Meeting.
Sign-up for La Jolla Pharmaceutical Company Announces Data Presentation at the American Society of Nephrology Kidney Week investment picks
La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that detailed results from its Phase 2 study of GCS-100 in chronic kidney disease (CKD) patients are being presented at a poster session ( Glomerular and Tubulointerstitial Disease: Clinical Trials and Outcomes , November 13, 10:00 a.m. - 12:00 p.m. Eastern Standard Time, Poster TH-PO460 ) at the American Society of Nephrology’s (ASN) Kidney Week Annual Meeting.
Sign-up for Results from Phase 2 Study of GCS-100 in Chronic Kidney Disease Being Presented at American Society of Nephrology Kidney Week investment picks
2014/11/6
Cigna (NYSE: CI) and the Connecticut State Medical Society-IPA , Inc. (CSMS-IPA), an independent practice association, have launched a collaborative care initiative to improve patient access to health care, enhance care coordination , and achieve the goal of improved health , affordability and patient experience .
Sign-up for Connecticut State Medical Society-IPA, Inc. and Cigna Launch Statewide Collaborative Care Program that Reaches Small and Mid-Size Medical Practices investment picks
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that 12 abstracts highlighting new clinical data on FoundationOne ® Heme will be presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition taking place December 6-9, 2014, at the Moscone Center in San Francisco.
Sign-up for Foundation Medicine and Collaborators to Present New Clinical Data on FoundationOne® Heme at the American Society of Hematology Annual Meeting investment picks
Fresenius Medical Care North America (FMCNA), the continent’s leading provider of kidney care products and services, announced today that it will be presenting a broad array of clinical research at this year’s American Society of Nephrology (ASN) Kidney Week 2014 conference.
Sign-up for Fresenius Medical Care to Present Extensive Research at the American Society of Nephrology’s Kidney Week 2014 Conference investment picks
Alnylam Pharmaceuticals , Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the publication of a peer-reviewed article in the Journal of the American Chemical Society describing the discovery of GalNAc-conjugated siRNA as a novel strategy for delivery of RNAi therapeutics.
Sign-up for New Paper in Journal of the American Chemical Society Documents Pioneering Discovery of GalNAc-Conjugated siRNA by Alnylam Scientists investment picks
A late-breaking poster presentation focused on five-year vision data from Lundbeck’s SABRIL (vigabatrin) patient registry was presented at the annual meeting of the American Epilepsy Society (AES). The data set includes 6,823 patients enrolled from August 21, 2009 through August 26, 2014.
Sign-up for Five-Year Data From SABRIL® (vigabatrin) Registry Presented at American Epilepsy Society Annual Meeting investment picks
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, will be showcasing its broad portfolio of vascular access solutions including Intraosseous Devices, CVCs, JACCs, Arterial Lines and PICCs at the 44 th annual Society of Critical Care Medicine, booth 801, January 17-21, 2015 in Phoenix, AZ.
Sign-up for Teleflex to Attend the Society of Critical Care Medicine's 44th Annual Critical Care Medicine Congress investment picks
2015/1/14
By Enda Curran And Joanne Chiu A planned three-way merger that would have created Malaysia's biggest bank has been shelved due to weak economic conditions.
Sign-up for CIMB Group, RHB Capital, Malaysia Building Society Shelve Merger Deal -- Update investment picks
Acceleron Pharma Inc. (NASDAQ: XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today reported that its collaboration partner, Celgene, and investigators on the sotatercept program will present preclinical and interim clinical data at the American Society of Nephrology (ASN) Kidney Week 2014.
Sign-up for Acceleron Collaboration Partner Celgene to Present Data at the American Society of Nephrology Kidney Week 2014 investment picks
Celgene Corporation (NASDAQ:CELG) today announced that data from more than 160 abstracts, including 39 oral presentations, evaluating Celgene investigational products and investigational uses of marketed products will be presented at the 56 th American Society of Hematology Annual Meeting between Dec.
Sign-up for Data from More Than 160 Abstracts Highlighting Celgene Therapies to Be Presented at American Society of Hematology Annual Meeting (ASH) investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Research Society
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Site  |  Next: Research Solutions